Common TitleOPTIMIST-2
Official Title Simeprevir plus Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection and Cirrhosis: A Phase 3 Study (OPTIMIST-2).
Phase Phase III
ClinicalTrials.gov NCT02114151
Treatments
Sofosbuvir
, Sofosbuvir
Tradename:SovaldiOther Names:SOFClass:FDA-ApprovedSimeprevir
Simeprevir
Tradename:OlysioOther Names:SMVClass:DiscontinuedFunding
IndustryJanssen